Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150000 participants
INTERVENTIONAL
2018-10-01
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Warning System for Clinical Deterioration on General Hospital Wards
NCT01280942
Development of an Automatically Generated and Wearable-based Early Warning System
NCT05699967
CHroniSense National Early Warning Score Study
NCT03448861
WARD-Home - Continuous Monitoring of Vital Parameters After Discharge
NCT05223504
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
NCT05378139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A standardized track and trigger system like EWS does not differentiate between different types of disease or the patient's individual physiological response. Therefore, there is a potential risk that the system fails to detect a patient with an abnormal stress response. Additionally; patients suffering from chronic illness might have different normal values than healthy patients, leading to unnecessarily excess observation, measurement, and suboptimal usage of limited staff resources.
Previous studies have shown that Early Warning System scores perform well for prediction of cardiac arrest and death within 48 hours, although the impact on health outcomes and resource utilization remains uncertain, often owing to methological limitations.
It is possible, but never studied before, whether the combination of vital signs with individual clinical assessment is a better tool for identifying hospitalized high-risk patients than the existing algorithms.
Further improvement and optimizing of the EWS is necessary, as there is potential to improve patient care and use staff resources more appropriate.
The purpose of the study is to investigate the impact of the I-EWS that has a systematic involvement of clinical assessment and the possibility to adjust the score, whilst keeping the same escalation protocol. I-EWS will be compared to the existing EWS with a focus on mortality, critical illness, and the use of staff resources.
Our hypothesis is that I-EWS, where clinical assessment is given a more prominent role will not increase the mortality among hospitalized patients but can reallocate personnel resources.
I-EWS is built in to electronic patient journal system "Sundhedsplatformen" it is only available in Sundhedsplatformen (SP) at hospitals assigned to I-EWS. Four hospitals are randomized to use I-EWS for 6,5 months, the remaining four hospitals are control hospitals using the current EWS in this period.
After 6,5 months a single cross-over will be preformed, and the previous control hospitals will use I-EWS over the next 6,5 months and the previous intervention hospitals, will go back to the current EWS for this period.
EWS scores and subsequent actions are documented in real time in SP. The first two weeks and final four weeks of each period will be excluded due to a implementation period. Data regarding patients, interventions and serious adverse events during hospitalization (i.e., cardiac arrest, the request of MET or unexpected death) will be accessed through SP and the Danish Central Registries (The Danish National Patient Registry, the Civil Registration System, DanArrest). After extraction, all data will be depersonalization and stored at a secured network in accordance with the current guidelines for data management in the Capital Region of Denmark.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm - standard EWS procedure
Standard use of the current implement Early Warning System, based on the principles of the National Early Warning Score and with a standard escalation protocol.
Standard EWS - Control (Trigger Tool)
Standard EWS - Based on principles of National Early Warning Score (NEWS)
Intervention Arm - I-EWS
Implementation of Individual Early Warning Score (I-EWS) with a systematic clinical assessment with a standard escalation protocol as intervention 7 parameters (Respiration rate, pulse, saturation, systolic blood pressure, consciousness, temperature, Oxygen) are registered , an aggregated score is generated. In the electronic patient journal (Sundhedsplatformen), the nursing staff is asked to reevaluate the aggregated score based on their clinical assessment of the patient. The aggregated score can be upgraded with up to 6 points and downgraded with up to 4.
This new I-EWS score interacts with the standard escalation protocol which defines the observation frequency and relevant clinical actions.
I-EWS with incorporated clinical assessment (Trigger Tool)
In relation to systematic measurement of vital parameters the nursing staff will perform an individual clinical assessment of the patient and adjust the I-EWS score accordingly.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
I-EWS with incorporated clinical assessment (Trigger Tool)
In relation to systematic measurement of vital parameters the nursing staff will perform an individual clinical assessment of the patient and adjust the I-EWS score accordingly.
Standard EWS - Control (Trigger Tool)
Standard EWS - Based on principles of National Early Warning Score (NEWS)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Participating hospitals are
* Herlev \& Gentofte Hospital
* Nordsjaellands Hospital
* Bispebjerg Hospital
* Rigshospitalet, Glostrup - Medical Ward
* Amager \& Hvidovre Hospital
* Zealand University Hospital
* Slagelse Hospital
* Holbaek Hospital
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kasper Iversen
Principal Investigator, Associate Professor, Consultant, DMSci
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kasper Iversen, MD, DMSci
Role: STUDY_DIRECTOR
Department of Cardiology, Herlev Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, Capital Region of Denmark, Denmark
Amager & Hvidovre Hospital
Copenhagen, Capital Region of Denmark, Denmark
Herlev & Gentofte Hospital
Copenhagen, Capital Region of Denmark, Denmark
Rigshospital, Glostrup, Medical Ward
Glostrup Municipality, Capital Region of Denmark, Denmark
Nordsjaellands Hospital
Hillerød, Capital Region of Denmark, Denmark
Holbaek Hospital
Holbæk, Region of Zealand, Denmark
Zealand University Hospital (Roskilde & Køge)
Roskilde, Region of Zealand, Denmark
Slagelse Sygehus
Slagelse, Region of Zealand, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nielsen PB, Langkjaer CS, Schultz M, Kodal AM, Pedersen NE, Petersen JA, Lange T, Arvig MD, Meyhoff CS, Bestle MH, Holge-Hazelton B, Bunkenborg G, Lippert A, Andersen O, Rasmussen LS, Iversen KK. Clinical assessment as a part of an early warning score-a Danish cluster-randomised, multicentre study of an individual early warning score. Lancet Digit Health. 2022 Jul;4(7):e497-e506. doi: 10.1016/S2589-7500(22)00067-X. Epub 2022 May 19.
Nielsen PB, Schultz M, Langkjaer CS, Kodal AM, Pedersen NE, Petersen JA, Lange T, Arvig MD, Meyhoff CS, Bestle M, Holge-Hazelton B, Bunkenborg G, Lippert A, Andersen O, Rasmussen LS, Iversen KK. Adjusting Early Warning Score by clinical assessment: a study protocol for a Danish cluster-randomised, multicentre study of an Individual Early Warning Score (I-EWS). BMJ Open. 2020 Jan 7;10(1):e033676. doi: 10.1136/bmjopen-2019-033676.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17017332
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.